Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Pal

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Nanomedicine (London, England)|November 22, 2023
Nanomedicine-fortified cosmeceutical serums for the mitigation of psoriasis and acnePriya Patel, Rohit Pal, Krishna Butani, et al.
Molecular Diversity|June 19, 2026
Pyrimidine derivatives as anticancer agents targeting kinases: design strategies, biological evaluation, and structure-activity relationship insightsManjushree Bv, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Biomolecular Structure & Dynamics|May 5, 2023
Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinaseGhanshyam Teli, Rohit Pal, Lalmohan Maji, et al.
Journal of Biomolecular Structure & Dynamics|August 29, 2023
An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)Rohit Pal, Ghanshyam Teli, Sindhuja Sengupta, et al.
Journal of Ayurveda and Integrative Medicine|July 4, 2025
Panchakarma treatment for painful Post-Traumatic Trigeminal Neuropathy - A case reportManoj Shamkuwar, Kiran Nimbalkar, Diwakar Mani Tripathi, et al.
Bioorganic Chemistry|August 21, 2024
Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure-activity relationshipRohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Analytical Chemistry|July 2, 2004
Phase change microvalve for integrated devicesRohit Pal, Ming Yang, Brian N Johnson, et al.
Chemistry & Biodiversity|April 19, 2025
Design, Synthesis, and Molecular Profiling of Pyrimidine-Furan Derivatives Targeting EGFR<sup>WT</sup>, EGFR<sup>T790M</sup>, and EGFR<sup>L858R/T790M/C797S</sup> in NSCLC: In Vitro and In Silico EvaluationRohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Bioimpacts : BI|April 21, 2025
<i>In-silico</i> based discovery of potential Keap1 inhibitors using the strategies of pharmacophore screening, molecular docking, and MD simulation studiesEkta Singh, Gurubasavaraja Swamy Purawarga Matada, Prasad Sanjay Dhiwar, et al.
European Journal of Medicinal Chemistry|June 20, 2025
BRAF inhibitors in Melanoma: Structural Insights, Therapeutic Resistance, and Biological Evaluation of Quinazoline DerivativesArghya Paik, Gurubasavaraja Swamy Purawarga Matada, Abhishek Ghara, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Nanomedicine (London, England)|November 22, 2023
Nanomedicine-fortified cosmeceutical serums for the mitigation of psoriasis and acnePriya Patel, Rohit Pal, Krishna Butani, et al.
Molecular Diversity|June 19, 2026
Pyrimidine derivatives as anticancer agents targeting kinases: design strategies, biological evaluation, and structure-activity relationship insightsManjushree Bv, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Biomolecular Structure & Dynamics|May 5, 2023
Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinaseGhanshyam Teli, Rohit Pal, Lalmohan Maji, et al.
Journal of Biomolecular Structure & Dynamics|August 29, 2023
An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)Rohit Pal, Ghanshyam Teli, Sindhuja Sengupta, et al.
Journal of Ayurveda and Integrative Medicine|July 4, 2025
Panchakarma treatment for painful Post-Traumatic Trigeminal Neuropathy - A case reportManoj Shamkuwar, Kiran Nimbalkar, Diwakar Mani Tripathi, et al.
Bioorganic Chemistry|August 21, 2024
Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure-activity relationshipRohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Analytical Chemistry|July 2, 2004
Phase change microvalve for integrated devicesRohit Pal, Ming Yang, Brian N Johnson, et al.
Chemistry & Biodiversity|April 19, 2025
Design, Synthesis, and Molecular Profiling of Pyrimidine-Furan Derivatives Targeting EGFR<sup>WT</sup>, EGFR<sup>T790M</sup>, and EGFR<sup>L858R/T790M/C797S</sup> in NSCLC: In Vitro and In Silico EvaluationRohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Bioimpacts : BI|April 21, 2025
<i>In-silico</i> based discovery of potential Keap1 inhibitors using the strategies of pharmacophore screening, molecular docking, and MD simulation studiesEkta Singh, Gurubasavaraja Swamy Purawarga Matada, Prasad Sanjay Dhiwar, et al.
European Journal of Medicinal Chemistry|June 20, 2025
BRAF inhibitors in Melanoma: Structural Insights, Therapeutic Resistance, and Biological Evaluation of Quinazoline DerivativesArghya Paik, Gurubasavaraja Swamy Purawarga Matada, Abhishek Ghara, et al.
Pageof 4